NCT06418308View on ClinicalTrials.gov

Intrathecal Dexmedetomidine vs Epinephrine

PHASE4RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 17, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cesarean SectionAnesthesia, Spinal
Interventions
DRUG

Dexmedetomidine

5 mcg of dexmedetomidine

DRUG

Epinephrine

200 mcg of epinephrine

DRUG

Standardized Spinal Mixture

Standardized spinal mixture of 10.25 mg hyperbaric bupivacaine, and 0.125 mg morphine.

Trial Locations (1)

10029

RECRUITING

Mount Sinai Hospital, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT06418308 - Intrathecal Dexmedetomidine vs Epinephrine | Biotech Hunter | Biotech Hunter